首页> 外文期刊>The oncologist >Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings
【24h】

Phase Angle and the Diagnosis of Impending Death in Patients with Advanced Cancer: Preliminary Findings

机译:先进癌症患者即将死亡的相位角度和诊断:初步调查结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background Phase angle is a prognostic factor in patients with months of survival, but its accuracy has not been examined in patients with weeks/days of survival. We determined the association between phase angle and survival in patients with advanced cancer admitted to an acute palliative care unit (APCU). Subjects, Materials, and Methods We prospectively assessed phase angle in consecutive patients with advanced cancer admitted to our APCU. We conducted univariate and multivariate survival analyses adjusting for established prognostic factors. Post hoc subgroup analyses examined patients with and without edema. Results Among 204 patients, the median overall survival was 10 days (95% confidence interval [CI] 8-11 days). Seventy-four (36%) did not have edema. The median phase angle was 3.7 degrees for the entire cohort, 3.9 degrees for the nonedematous subgroup and 3.6 degrees for the edematous subgroup. In univariate analysis, a low phase angle was associated with decreased survival for the entire cohort ( 3 degrees, median survival 7 vs. 10 days, p = .045) and the nonedematous subgroup (5 vs. 18 days, p < .001) but not the edematous subgroup (9 vs. 9 days, p = .84). In multivariate analysis, phase angle did not reach significance for the entire cohort but remained significant in the nonedematous subgroup (hazard ratio 2.46, 95% CI 1.14-5.31, p < .001). Specifically, phase angle <= 3 degrees had an accuracy of 86% (95% CI 77%-93%) for 3-day survival in patients without edema. Conclusion Phase angle had limited prognostic utility in unselected APCU patients but was significant in the nonedematous subgroup. Further studies are required to confirm these preliminary findings. Implications for Practice In this prospective study involving 204 patients with advanced cancer, phase angle as measured by bioelectric impedance analysis was a significant predictor of mortality independent of known prognostic factors in patients without edema but not patients with edema. Among patients without edema, a phase angle <= 3 degrees had an accuracy of 86% for 3-day survival, which may inform the diagnosis of impending death and potentially end-of-life decision making.
机译:背景技术相位角是生存月份患者的预后因素,但其在存活周/天的患者中尚未检查其准确性。我们确定进入急性姑息治疗单元(APCU)的晚期癌症患者的相角和生存之间的关联。我们预期癌症的连续患者预期评估了相角的受试者,材料和方法。我们进行了单变量和多变量的存活分析调整既定的预后因素。 HOC亚组分析检查患者,无需水肿。结果204例患者之间,中位数总存活率为10天(95%置信区间[CI] 8-11天)。七十四(36%)没有水肿。整个队列的中值相位角为3.7度,对于非态性子组的3.9度,为水肿子组3.6度。在单变量分析中,低相位角与整个群组的存活率降低(3度,中值存活7与10天,P = .045)和非eddemat亚组(5 vs.18天,P <.001)但不是水肺子组(9 vs. 9天,p = .84)。在多变量分析中,相位角对整个群组没有达到意义,但在非酸性亚组(危险比2.46,95%CI 1.14-5.31,P <.001)中保持显着。具体地,相位角<= 3度的准确度为86%(95%CI 77%-93%),在没有水肿的患者中为3天存活率。结论相角在未选择的APCU患者中具有有限的预后效用,但在非渗透亚组中是显着的。需要进一步的研究来确认这些初步结果。在这种前瞻性研究中对实践的影响涉及204例通过生物电阻抗分析测量的前瞻性癌症患者,相位角是由于没有水肿的患者的已知预后因素,但没有水肿的患者,这是一个显着的死亡率。在没有水肿的患者中,相位角度<= 3度的准确度为3天存活率为86%,这可能会通知诊断即将发生的死亡和潜在的生命结束决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号